María Eugenia
Alonso Sarasquete
Investigadora desde 2011
Hospital Universitario de Valladolid
Valladolid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Valladolid (16)
2021
-
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
British Journal of Haematology, Vol. 192, Núm. 5, pp. 843-852
-
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping
British Journal of Haematology, Vol. 195, Núm. 4, pp. 542-551
2020
-
Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients
British Journal of Haematology, Vol. 189, Núm. 4, pp. 718-730
2018
-
Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study
Annals of Hematology, Vol. 97, Núm. 3, pp. 475-484
2017
-
Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes
Thrombosis and Haemostasis, Vol. 117, Núm. 1, pp. 66-74
2016
-
Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders
Haemophilia, Vol. 22, Núm. 4, pp. 590-597
-
MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion
Leukemia Research, Vol. 46, pp. 30-36
2015
-
MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL
BMC Cancer, Vol. 15, Núm. 1
-
The cellular origin and malignant transformation of Waldenström macroglobulinemia
Blood, Vol. 125, Núm. 15, pp. 2370-2380
2014
-
Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia
BioMed Research International, Vol. 2014
2013
-
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia
Leukemia, Vol. 27, Núm. 8, pp. 1722-1728
2012
2010
-
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
Annals of Hematology, Vol. 89, Núm. 5, pp. 453-458
-
Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients
Haematologica, Vol. 95, Núm. 5, pp. 745-751
2009
-
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics
Leukemia Research, Vol. 33, Núm. 12, pp. 1706-1709
-
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
Blood, Vol. 114, Núm. 1, pp. 148-152